Dashboard


CROS NT Appoints Sébastien Gerin as Chief Operating Officer

08/20/2019 15:00 - Italy - (PR Distribution™)

CROS NT announces that Sébastien Gerin has recently joined its global team in the role of Chief Operating Officer.

Sébastien stepped into the new position this June as CROS NT continues to expand its global operations in terms of expert biometrics services and full service capacity in select geographic areas. He oversees all of CROS NT’s global operations throughout Europe, North America and India.

Sébastien is a statistical programmer by background and has spent 20 years in the drug development industry. He has covered roles on both the Sponsor and CRO side including 14 years with Merck Serono where he was global head of Statistical Programming, before entering the CRO world to successfully lead and develop Biostatistics and Data Management global operations.

CROS NT CEO, Paolo Morelli, said, “as a data-driven CRO and global player in the biometrics services market, Sébastien is the perfect fit to lead CROS NT operations. He understands data, and he understands the importance and power of data to the success of clinical research. More importantly, he understands, and is passionate about, the role data is playing in the digital transformation of trials where CROS NT is moving. His expertise and experience will make CROS NT an even stronger biometrics powerhouse”.

Sébastien added, “I am excited to join CROS NT. Over the last years, CROS NT has built a strong platform for future success, focusing on delivering top quality services in biostatistics and data management, and is now growing in the digital health field through their R&D Lab, this is very promising”.

Sébastien is based in Europe.


Founded in 1992, CROS NT is a global Contract Research Organization (CRO). With a strong heritage in clinical data management and biostatistics, CROS NT enhances clinical trial outcomes and optimizes vendor oversight with data-driven services and eClinical solutions.
Our data-driven approach facilitates excellent quality control, data standardization, data integration, traceability, data visualization, vendor oversight and data analytics.

Services include clinical data management, biostatistics programming and analysis, pharmacovigilance, regulatory consultancy, monitoring and study setup, and medical writing – all underpinned by strong project management.

These services are supported by industry-leading and proprietary technologies including data visualization, clinical analytics, EDC, eCOA, IVR, data anonymization and data integrity analytics. We are also leading the charge in digital transformation in healthcare solutions including wearables and IoT.

Media Contacts:


Full Name
Mary Wieder
Company
CROS NT
Phone Number
Website
Email
View Results in Google
Promote Your Business keyboard_arrow_right